Shopping Cart
Remove All
Your shopping cart is currently empty
Rabbit Anti-Human IgA Secondary Antibody-APC is a APC-conjugated Rabbit antibody targeting IgA. Rabbit Anti-Human IgA Secondary Antibody-APC can be used in FCM,ICC/IF,IF.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 μL | $475 | 7-10 days | 7-10 days | |
| 1 mL | $3,585 | 7-10 days | 7-10 days |
| Description | Rabbit Anti-Human IgA Secondary Antibody-APC is a APC-conjugated Rabbit antibody targeting IgA. Rabbit Anti-Human IgA Secondary Antibody-APC can be used in FCM,ICC/IF,IF. |
| Synonyms | Rabbit Anti-Human IgA (APC) |
| Ig Type | IgG |
| Reactivity | Human |
| Application | |
| Recommended Dose | IF: 1:100-1000; FCM: 1:100-1000; ICC/IF: 1:100-1000 |
| Antibody Type | Polyclonal |
| Host Species | Rabbit |
| Construction | Polyclonal Antibody |
| Purification | Protein A purified |
| Appearance | Liquid |
| Formulation | 10 mM TBS (pH=7.4) with 1% BSA, 0.03% Proclin300 and 50% glycerol. |
| Concentration | 1.0 mg/ml |
| Research Background | Monomeric IgA constitutes 5-15 % of the serum immunoglobulins whereas dimeric IgA is localized to mucosa surfaces such as saliva, gastrointestinal secretion, bronchial fluids and milk. Mucosal IgA plays a major role in host defence by neutralising infectious agents at mucosal surfaces. The production is usually local and antigen specific IgA producing B-cells can be found in regions under the lamina propria where they mature into dimeric IgA producing plasma cells. IgA deficiency is the most common immunodeficiency that may affect both serum and mucosal produced IgA. |
| Immunogen | Native Human IgA |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.